KalVista Pharmaceuticals | 4:持股變動聲明-高管 Yea Christopher
KalVista Pharmaceuticals | 4:持股變動聲明-高管 Audhya Paul K.
KalVista Pharmaceuticals | 4:持股變動聲明-高管 Feener Edward P.
KalVista Pharmaceuticals | 4:持股變動聲明-高管 Audhya Paul K.
KalVista Pharmaceuticals | 4:持股變動聲明-高管 Palleiko Benjamin L
KalVista Pharmaceuticals | 4:持股變動聲明-高管 Yea Christopher
KalVista Pharmaceuticals | 4:持股變動聲明-董事 Fairey William
KalVista Pharmaceuticals | 3:首次持股聲明-董事 Fairey William
KalVista Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-TCG Crossover GP I, LLC(3.2%),TCG Crossover Fund I, L.P.(3.2%)等
KalVista Pharmaceuticals | 4:持股變動聲明-高管 Palleiko Benjamin L
KalVista Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Adage Capital Partners, L.P.(6.87%),Adage Capital Partners GP, L.L.C.(6.87%)等
KalVista Pharmaceuticals | 4:持股變動聲明-股東 Venrock Healthcare Capital Partners III, L.P.
KalVista Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-James N. Topper(8.9%),Patrick J. Heron(8.9%)等
KalVista Pharmaceuticals | 4:持股變動聲明-高管 Feener Edward P.
KalVista Pharmaceuticals | 4:持股變動聲明-高管 Yea Christopher
KalVista Pharmaceuticals | 4:持股變動聲明-高管 Palleiko Benjamin L
KalVista Pharmaceuticals | 4:持股變動聲明-高管 Audhya Paul K.
KalVista Pharmaceuticals | 4:持股變動聲明-高管 Crockett Thomas Andrew
KalVista Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-TCG Crossover GP I, LLC(6.52%),TCG Crossover Fund I, L.P.(6.52%)等
KalVista Pharmaceuticals | 4:持股變動聲明-高管 Yea Christopher
暫無數據